Federated Hermes’s Juniper Pharmaceuticals, Inc. Common Stock JNP Stock Holding History

Federated Hermes’s Portfolio JNP Stock Details JNP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-903	Closed	-$8K	–	2392
2018 Q2	$8K	Sell	903 -761	-46%	-$6.85K	﹤0.01%	1956
2018 Q1	$17K	Buy	1,664 +74	+5%	+$622	﹤0.01%	1796
2017 Q4	$8K	Buy	+1,590	New	+$7.73K	﹤0.01%	1936
2015 Q4	–	Sell	-471	Closed	-$6K	–	2198
2015 Q3	$6K	Sell	471 -66	-12%	-$729	﹤0.01%	1775
2015 Q2	$5K	Buy	+537	New	+$4.05K	﹤0.01%	1809
2014 Q3	–	Sell	-557	Closed	-$4K	–	2102
2014 Q2	$4K	Buy	+557	New	+$3.73K	﹤0.01%	1881

Federated Hermes's JNP Position: Q3 2018 in Review

Federated Hermes sold out of Juniper Pharmaceuticals, Inc. Common Stock (JNP) in Q3 2018, closing a stake of 903 shares — an estimated $8K sold.

Federated Hermes first reported a position in JNP in Q2 2014 and held it in 6 quarters. The position peaked at $17K in Q1 2018. 0 funds tracked by Wall St. Rank hold JNP as of Q3 2018.

Federated Hermes reported no remaining Juniper Pharmaceuticals, Inc. Common Stock position as of Q3 2018 after selling out during the quarter.
Federated Hermes sold 903 Juniper Pharmaceuticals, Inc. Common Stock shares in Q3 2018, an estimated $8K.
Federated Hermes first reported a position in Juniper Pharmaceuticals, Inc. Common Stock in Q2 2014 and held it in 6 quarters.
Federated Hermes's Juniper Pharmaceuticals, Inc. Common Stock position peaked at $17K in Q1 2018.
0 funds tracked by Wall St. Rank held Juniper Pharmaceuticals, Inc. Common Stock as of Q3 2018.

Based on Federated Hermes's 13F filing for Q3 2018, filed 13 Nov 2018.